Transcendent Capital Group »

Bristol Myers Squibb shares owned by Transcendent Capital Group

Quarter-by-quarter ownership of Bristol Myers Squibb (BMY) shares owned by Transcendent Capital Group from 13F filings

Historical chart of Transcendent Capital Group investment in Bristol Myers Squibb

Tip: Access up to 7 years of quarterly data

All positions including Bristol Myers Squibb held by Transcendent Capital Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bristol Myers Squibb by Transcendent Capital Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $318k 5.9k 53.94
2024-12-31 $265k 4.7k 56.56
2024-09-30 $9.9k 192 51.74

More positions owned by Transcendent Capital Group

Allianzim Buffer 15 Uncapped Allocation Etf Allianzim Buf 15 (SPBU)
First Trust Etf Iv First Trust Enhanced Short First Tr Enh New (FTSM)
Microsoft Corporation (MSFT)
Apple (AAPL)
Ishares Tr Core S&p Mcp Etf Core S&p Mcp Etf (IJH)
Ishares Tr Core S&p500 Etf Core S&p500 Etf (IVV)
Ishares Tr S&p 500 Grwt Etf S&p 500 Grwt Etf (IVW)
Invesco Ultra Short Duration Etf Ultra Shrt Dur (GSY)
State Street Spdr Portfolio S&p Etf State Street Spd (SPYM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation (NVDA)
Capital Group Core Equity Etf Shs Creation Unit Shs Creation Uni (CGUS)
Vanguard Large-cap Etf Large Cap Etf (VV)
Ea Ser Tr Alpha Architect 1-3 Month Box Alpha Arch 1-3 (BOXX)
Ishares Tr Core S&p Scp Etf Core S&p Scp Etf (IJR)

View all positions for Transcendent Capital Group

Top funds holding Bristol Myers Squibb

Vanguard Group
BlackRock
State Street Corporation
Jpmorgan Chase & Co
Charles Schwab Investment Management
Geode Capital Management
Norges Bank Investment Management
Ameriprise Financial
PRIMECAP Management Company
Northern Trust
Bank of New York Mellon
Ubs Global Asset Management Americas
Capital Research and Management Company - Division 3
Independent Franchise Partners
Goldman Sachs Group

View all funds holding Bristol Myers Squibb